Um die anderen Arten von Veröffentlichungen zu diesem Thema anzuzeigen, folgen Sie diesem Link: Therapeutic use.

Zeitschriftenartikel zum Thema „Therapeutic use“

Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an

Wählen Sie eine Art der Quelle aus:

Machen Sie sich mit Top-50 Zeitschriftenartikel für die Forschung zum Thema "Therapeutic use" bekannt.

Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.

Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.

Sehen Sie die Zeitschriftenartikel für verschiedene Spezialgebieten durch und erstellen Sie Ihre Bibliographie auf korrekte Weise.

1

Neekhra, Sachin, Himani Awasthi und DCP Singh. „Potential Therapeutic use of Streblus asper: A Review“. International Journal of Research and Development in Pharmacy & Life Sciences 6, Nr. 7 (Dezember 2017): 2845–49. http://dx.doi.org/10.21276/ijrdpl.2278-0238.2017.6(7).2845-2849.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
2

Dvorak, J. „Therapeutic use exemption“. British Journal of Sports Medicine 40, Supplement 1 (01.07.2006): i40—i42. http://dx.doi.org/10.1136/bjsm.2006.027490.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
3

Nadler, S. F., M. A. Prybicien, D. Sicher, G. A. Malanga, M. DePrince und J. E. Bowen. „THERAPEUTIC MODALITY USE“. Medicine & Science in Sports & Exercise 33, Nr. 5 (Mai 2001): S90. http://dx.doi.org/10.1097/00005768-200105001-00519.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
4

Pradhan, Leena, Nicholas D. Andersen, Christoph Nabzdyk, Frank W. LoGerfo und Aristidis Veves. „Wound-healing Abnormalities in Diabetes and New Therapeutic Interventions“. US Endocrinology 00, Nr. 01 (2007): 68. http://dx.doi.org/10.17925/use.2007.00.1.68.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
5

Gallagher, Lisa M., und Francois Bethoux. „Therapeutic use of the Arts for Patients with Multiple Sclerosis“. US Endocrinology 13, Nr. 02 (2017): 82. http://dx.doi.org/10.17925/use.2017.13.02.82.

Der volle Inhalt der Quelle
Annotation:
People with multiple sclerosis (MS) face a wide variety of physical, emotional, and social challenges. A multidisciplinary comprehensive care approach is recommended for the management of MS and its consequences, and non-traditional treatments are increasingly considered by patients and health care providers, particularly for the promotion of wellness in the context of this chronic disease. Previous research has demonstrated the benefits of the therapeutic arts (art therapy, dance and movement therapy, and music therapy) in addressing some of the physiological, psychological, cognitive, social, and spiritual needs of patients facing a variety of chronic illnesses. Our review of the literature suggests that therapeutic art can be beneficial to individuals with MS, particularly in promoting self-efficacy, emotional well-being, and motor control. However, the body of evidence is limited, and further research is needed regarding the outcomes and mechanism of action of therapeutic arts in MS to better understand their role in the management of the consequences of the disease.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
6

Groeneweg, Stefan, Robin P. Peeters, Theo J. Visser und W. Edward Visser. „Diagnostic and Therapeutic Challenges in the Allan—Herndon—Dudley Syndrome“. US Endocrinology 12, Nr. 02 (2016): 90. http://dx.doi.org/10.17925/use.2016.12.02.90.

Der volle Inhalt der Quelle
Annotation:
Thyroid hormone (TH) is important for normal brain development. The TH transporter protein monocarboxylate transporter 8 (MCT8) is crucial to maintain adequate TH levels in the brain during development and throughout life. Mutations in MCT8 result in the Allan–Herndon–Dudley syndrome (AHDS), which is characterized by a severe delay in neurocognitive development, combined with abnormal serum thyroid function tests (TFTs). The combination of an increased (F)T3 and decreased (F)T4 and rT3 serum levels are characteristic for the presence of AHDS in male patients with moderate to severe delay in neurocognitive development. Here, we provide an overview of current insights, challenges and pitfalls in the diagnosis and management of patients with AHDS.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
7

Tan, Robert S., Chris Ojeih und Maurita Carrejo. „Potential Therapeutic Role of Androgens in Cognitive Loss Associated with Hypogonadism“. US Endocrinology 00, Nr. 01 (2005): 1. http://dx.doi.org/10.17925/use.2005.00.01.1a.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
8

Tan, Robert S., Chris Ojeih und Maurita Carrejo. „Potential Therapeutic Role of Androgens in Cognitive Loss Associated with Hypogonadism“. US Endocrinology 00, Nr. 01 (2005): 84. http://dx.doi.org/10.17925/use.2005.00.01.84.

Der volle Inhalt der Quelle
Annotation:
Memory problems late in life are common and are often easy to recognize. Hypogonadism in older men is not as readily identified, but it is also frequently a part of aging. Androgens, such as testosterone, have important hormonal influences on the brain and may prevent and possibly treat cognitive loss, including age-associated memory loss, mild cognitive impairment (MCI), and perhaps even Alzheimer’s disease (AD).There is support from small, prospective clinical trials that suggest the role of testosterone in improving cognitive function in normal men as well as hypogonadal men with AD. This improvement in cognitive function is subtle and is often only measurable on specialized neuropsychological batteries such as those that measure the visual-spatial domain. Patients often report measurable memory improvement in both declarative and procedural domains after receiving testosterone replacement therapy.The rise of gonadotropins, follicle-stimulating hormones (FSHs), and luteinizing hormones (LHs), has been associated with AD.The clinical significance of therapeutic strategies directed to reduce these levels remains to be determined. Current evidence showing that dehydroepiandrosterone (DHEA) improves cognitive function is ambiguous.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
9

Rodriguez, Mariano, Juan Munoz-Castaneda und Yolanda Almaden. „Therapeutic Use of Calcitriol“. Current Vascular Pharmacology 12, Nr. 2 (April 2014): 294–99. http://dx.doi.org/10.2174/15701611113119990021.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
10

Wall, Jenny, Sally Davis und Samantha Ridgway. „Cannabis: its therapeutic use“. Nursing Standard 16, Nr. 10 (21.11.2001): 39–44. http://dx.doi.org/10.7748/ns2001.11.16.10.39.c3123.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
11

Hogaboam, Cory, Cynthia Bone-Larson, Akihiro Matsukawa, Matthew Steinhauser, Kate Blease, Nicholas Lukacs und Steven Kunkel. „Therapeutic Use of Chemokines“. Current Pharmaceutical Design 6, Nr. 6 (01.04.2000): 651–63. http://dx.doi.org/10.2174/1381612003400605.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
12

Whall, Ann L. „THERAPEUTIC USE OF SELF“. Journal of Gerontological Nursing 14, Nr. 2 (01.02.1988): 38–39. http://dx.doi.org/10.3928/0098-9134-19880201-09.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
13

Jones, Janet. „Therapeutic use of metaphor“. Nursing Standard 6, Nr. 11 (04.12.1991): 30–32. http://dx.doi.org/10.7748/ns.6.11.30.s34.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
14

Hebert, Steven C. „Therapeutic Use of Calcimimetics“. Annual Review of Medicine 57, Nr. 1 (Februar 2006): 349–64. http://dx.doi.org/10.1146/annurev.med.57.121304.131328.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
15

&NA;, &NA;. „Therapeutic Use for Nicotine?“ AJN, American Journal of Nursing 94, Nr. 6 (Juni 1994): 50. http://dx.doi.org/10.1097/00000446-199406000-00025.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
16

Pridmore, Saxby. „Therapeutic use of rTMS“. Nature Reviews Neuroscience 8, Nr. 10 (Oktober 2007): 808. http://dx.doi.org/10.1038/nrn2169-c1.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
17

Ridding, Michael C., und John C. Rothwell. „Therapeutic use of rTMS“. Nature Reviews Neuroscience 8, Nr. 10 (Oktober 2007): 808. http://dx.doi.org/10.1038/nrn2169-c2.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
18

DE Gaudio, A. R. „Therapeutic Use of Albumin“. International Journal of Artificial Organs 18, Nr. 4 (April 1995): 216–24. http://dx.doi.org/10.1177/039139889501800407.

Der volle Inhalt der Quelle
Annotation:
The clinical use of albumin solutions is a controversial issue, that involves albumin as a volume plasma expander, a supplement of total parenteral nutrition and a substance with pharmacological properties. The aim of this review is to show the present role of albumin in the clinical setting. We reviewed experimental and clinical data collected by the Medline System and the bibliographies of relevant articles. Experimental studies were selected on the basis of their historical value and applicability (hypothetical use, correct use) to the clinical setting. At present, it is possible to assert that: a) exogenous albumin is not an ideal colloid; b) the effects on plasma volume expansion are not entirely predictable, especially in pathologic states accompanied by leaky capillary membranes; c) albumin supplementation shows no benefit on many kinds of tissue edema; d) the supplementation of albumin has no influence on outcome. It is possible to demonstrate the role of albumin as a substance with unique properties that make it useful, but further experimental and clinical data will be necessary and represent new areas for future exploration. Given the protein's cost, the routine use of albumin does not appear to be justified, until new data indicate otherwise.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
19

Soothill, James, Catherine Hawkins, Erik Änggår und David Harper. „Therapeutic use of bacteriophages“. Lancet Infectious Diseases 4, Nr. 9 (September 2004): 544–45. http://dx.doi.org/10.1016/s1473-3099(04)01127-2.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
20

Grotenhermen, Franjo. „Therapeutic use of cannabis“. Lancet 351, Nr. 9104 (März 1998): 758–59. http://dx.doi.org/10.1016/s0140-6736(05)78538-x.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
21

Winblad, Bengt, Mario Fioravanti, Tomas Dolezal, Inara Logina, Ivan Gospodinov Milanov, Dinu Cristian Popescu und Alina Solomon. „Therapeutic Use of Nicergoline“. Clinical Drug Investigation 28, Nr. 9 (2008): 533–52. http://dx.doi.org/10.2165/00044011-200828090-00001.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
22

Stiehm, E. Richard, Jordan S. Orange, Mark Ballow und Heather Lehman. „Therapeutic Use of Immunoglobulins“. Advances in Pediatrics 57, Nr. 1 (Januar 2010): 185–218. http://dx.doi.org/10.1016/j.yapd.2010.08.005.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
23

Grotenhermen, Franjo. „Cannabinoids for Therapeutic Use“. American Journal of Drug Delivery 2, Nr. 4 (2004): 229–40. http://dx.doi.org/10.2165/00137696-200402040-00003.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
24

Shore, Lisa B. „Therapeutic Use of Touch“. Pediatric Physical Therapy 9, Nr. 1 (1997): 41. http://dx.doi.org/10.1097/00001577-199700910-00016.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
25

Goelitz, Ann, und Abigail Stewart Kahn. „Therapeutic Use of Space“. Journal of Creativity in Mental Health 2, Nr. 4 (04.03.2008): 31–44. http://dx.doi.org/10.1300/j456v02n04_04.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
26

Balazs, Endre A. „Therapeutic use of hyaluronan“. Structural Chemistry 20, Nr. 2 (04.03.2009): 341–49. http://dx.doi.org/10.1007/s11224-009-9435-y.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
27

Kamra, Pooja, Mahaveer Singh, Hardarshan Singh Lamba und Birendra Srivastava. „Scientific Basis for the Therapeutic use of Plectranthus ambonicus: A Review“. International Journal of Pharma Research and Health Sciences 7, Nr. 6 (Dezember 2019): 3072–80. http://dx.doi.org/10.21276/ijprhs.2019.06.01.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
28

Singh, Kalpana, und Arvind Kumar Srivastava. „THERAPEUTIC USES OF BUTEA MONOSPERMA“. Era's Journal of Medical Research 9, Nr. 2 (Dezember 2022): 218–23. http://dx.doi.org/10.24041/ejmr2022.34.

Der volle Inhalt der Quelle
Annotation:
New synthetic drugs have many side effects on health as compared to the traditional herbs used in the past.The use of medicinal plants have been en established source for a relief from illness which can be traced back over five millennia. Antibiotics are one of the life saving weapons for humans but over the past few decades these health benefits are under threat as antibiotics have become less effective and also create toxic after effects affecting human life more. The well-known medicinal herb Butea monosperma is a moderately Sizeable deciduous tree and is widely dispersed in Asian hemispheres, Burma and Sri Lanka. From time to time it has been used in traditional medicinal practices. It has been mentioned in ayurveda for medicinal uses and mythological references, also The population's health care system continues to be heavily influenced by traditional medical practises, homoeopathy, and folklore. Rural and tribal people utilise the herb extensively to treat a variety of ailments. It is known in many languages apart from its botanical name. It is called Flame of forest, Dhak, Palash etc. It has been used to treat a variety of illnesses including cancer, diabetes, dysentery, fever, jaundice, diarrhoea, and jaundice, among others. A great variety of phytochemicals, primarily flavonoids, lactones, diterpenoids, phytosterols, etc., are present in the plant's aerial portion. The need for new antimicrobial compounds from alternative sources has arisen as a result of the development of drug resistance in human infections against routinely used antibiotics. Finding possible novel chemicals for therapeutic purposes requires screening medicinal plants for antibacterial and phytochemical properties .
APA, Harvard, Vancouver, ISO und andere Zitierweisen
29

Salvi, Mario, Guia Vannucchi und Paolo Beck-Peccoz. „Rituximab for the Treatment of Graves’ Orbitopathy“. US Endocrinology 07, Nr. 02 (2011): 130. http://dx.doi.org/10.17925/use.2011.07.02.130.

Der volle Inhalt der Quelle
Annotation:
The contribution of B-cells to human autoimmune disease has recently been underscored because of the therapeutic benefit of B-cell depleting therapies. B-cells are involved in the production of autoantibodies, and in CD4+ T-cell activation, control of T-cell function, and inflammation through cytokine production. B-cells are also important antigen-presenting cells. Rituximab (RTX) has been used off-label in various autoimmune disorders and has been shown to effectively deplete mature and memory CD20+ B-cells, but not long-lived plasma cells. The rationale behind the use of RTX in Graves’ disease (GD) and Graves’ orbitopathy (GO) relies on its putative effect on pathogenic autoantibodies causing hyperthyroidism. RTX in patients with active GO has been shown to have a significant effect on the inflammatory activity and severity of GO. However, caution is suggested before proposing RTX as a novel therapeutic tool in this disease until randomized controlled trials are available. Should preliminary observations be confirmed, an optimal strategy for controlling the progression of GO would be to pursue B-cell depletion shortly after diagnosis, rather than only as an alternative therapeutic option when standard immunosuppression has failed.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
30

Alam, Md Khorshed, Md Obydul Hoq und Md Shahab Uddin. „Therapeutic use of Withania somnifera“. Asian Journal of Medical and Biological Research 2, Nr. 2 (09.08.2016): 148–55. http://dx.doi.org/10.3329/ajmbr.v2i2.29004.

Der volle Inhalt der Quelle
Annotation:
Withania somnifera (L) Dunal is commonly called as Ashwagandha/Asgand and it belongs to the family Solanaceae. It is a well known medicinal plant widely used in the treatment of many clinical conditions in Indian subcontinent. It is an important medicinal plant commonly known as Asgand which has been used either single or in combination with other drugs in Unani as well as Ayurvedic system of medicine for centuries. It has been described by Dioscorides (78 AD) in his book “Kitab-ul-Hashaish”. Asgand consists of the roots of Withania somnifera which has various therapeutic actions such as anti - inflammatory (Muhallil-e-Warm), sedative (Musakkin), aphrodisiac (Muqawwi-e-Bah), hepatoprotective, immune-modulator activity, anti-oxidant, anti-ageing, anti-tumour activity, adaptogenic activity and has anti-anticonvulsant activity. Keeping in view the medicinal properties of Withania somnifera Dunal (Asgand), an attempt has been made in this paper to explore various dimensions of the drug including phytochemical and pharmacological studies carried out on this herb.Asian J. Med. Biol. Res. June 2016, 2(2): 148-155
APA, Harvard, Vancouver, ISO und andere Zitierweisen
31

Hossain, Md Tofazzal, und Md Obydul Hoq. „Therapeutic use of Adhatoda vasica“. Asian Journal of Medical and Biological Research 2, Nr. 2 (09.08.2016): 156–63. http://dx.doi.org/10.3329/ajmbr.v2i2.29005.

Der volle Inhalt der Quelle
Annotation:
Adhatoda vasica Nees belonging to family Acanthaceae, commonly known as Adosa, is found many regions of India and throughout the world, with a multitude of uses in traditional Unani and Ayurvedic systems of medicine. It is also called “Vasaka”. It is a well-known herb in indigenous systems of medicine for its beneficial effects, particularly in bronchitis. Vasaka leaves, bark, the root bark, the fruit and flowers are useful in the removal of intestinal parasites. Vasaka herb is used for treating cold, cough, chronic bronchitis and asthma. In acute stages of bronchitis, vasaka gives unfailing relief, especially where the sputum is thick and sticky. It liquefies the sputum so that it is brought up more easily. For relief in asthma, the dried leaves should be smoked. The juice from its leaves should be given in doses of 2 to 4 grams in treating diarrhea and dysentery. A poultice of its leaves can be applied with beneficial results over fresh wounds, rheumatic joints and inflammatory swellings. A warm decoction of its leaves is useful in treating scabies and other skin diseases. In olden times its leaves were made into a decoction with pepper and dried ginger. But the modern medicine searched its active ingredients and found out that vasicine, oxyvascicine and vasicinone are the alkaloids present in vasaka and in which vasicine is the active ingradient for expelling sputum from the body.Asian J. Med. Biol. Res. June 2016, 2(2): 156-163
APA, Harvard, Vancouver, ISO und andere Zitierweisen
32

Nasser, Abdullah. „Ready-to-use therapeutic foods“. University of Western Ontario Medical Journal 83, Nr. 2 (23.12.2014): 26–27. http://dx.doi.org/10.5206/uwomj.v83i2.4440.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
33

Medeiros, Aldo Cunha, und Vanessa De Fátima Lima de Paiva Medeiros. „Therapeutic use of coconut water“. JOURNAL OF SURGICAL AND CLINICAL RESEARCH 3, Nr. 2 (03.06.2013): 83. http://dx.doi.org/10.20398/jscr.v3i2.3570.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
34

Poulton, James L., und Donald S. Strassberg. „The Therapeutic Use of Reminiscence“. International Journal of Group Psychotherapy 36, Nr. 3 (Juli 1986): 381–98. http://dx.doi.org/10.1080/00207284.1986.11490910.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
35

Bell, Susan Givens. „The Therapeutic Use of Honey“. Neonatal Network 26, Nr. 4 (Juli 2007): 247–51. http://dx.doi.org/10.1891/0730-0832.26.4.247.

Der volle Inhalt der Quelle
Annotation:
THE ANCIENTS WROTE OF THE healing properties of honey. A Sumerian tablet, possibly dated 3000 BCE, documents the treatment of an infected skin ulcer with honey. An Egyptian papyrus dated around 2000 BCE notes the use of honey to treat a gaping wound penetrating to the bone near the eyebrow. Aristotle (384–322 BCE) wrote about the use of honey to treat wounds and sore eyes. As with those of other natural substances, the healing benefits of honey were passed from generation to generation. Honey continues to be a popular medicine throughout the world, except in the U.S.1
APA, Harvard, Vancouver, ISO und andere Zitierweisen
36

Salladay, Susan A. „Should Christians Use Therapeutic Touch?“ Christian bioethics: Non-Ecumenical Studies in Medical Morality 8, Nr. 1 (01.04.2002): 25–42. http://dx.doi.org/10.1093/chbi.8.1.25.8756.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
37

Ehrenfeld, M., und R. Bergman. „The Therapeutic Use of Dolls“. Perspectives in Psychiatric Care 31, Nr. 4 (16.01.2009): 21–22. http://dx.doi.org/10.1111/j.1744-6163.1995.tb00484.x.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
38

Bechler-Karsch, Abby. „The Therapeutic Use of Music“. Worldviews on Evidence-Based Nursing E1, Nr. 1 (Dezember 1994): 23–33. http://dx.doi.org/10.1111/j.1524-475x.1993.00023.x.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
39

Brock, Medina. „The Therapeutic Use of Clay“. British Journal of Occupational Therapy 54, Nr. 1 (Januar 1991): 13–15. http://dx.doi.org/10.1177/030802269105400108.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
40

Krenning, Eric P., und Marion de Jong. „Therapeutic use of radiolabelled peptides“. Annals of Oncology 11 (2000): 267–72. http://dx.doi.org/10.1093/annonc/11.suppl_3.267.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
41

Rode, Diane, Kathleen Leask Capitulo, Merri Fishman und Gary Holden. „The Therapeutic Use of Technology“. American Journal of Nursing 98, Nr. 12 (Dezember 1998): 32–35. http://dx.doi.org/10.1097/00000446-199812000-00037.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
42

Rode, Diane, Kathleen Leask Capitulo, Merri Fishman und Gary Holden. „The Therapeutic Use of Technology“. AJN, American Journal of Nursing 98, Nr. 12 (Dezember 1998): 32–35. http://dx.doi.org/10.1097/00000446-199898120-00021.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
43

Andrews, A. „Therapeutic use of bovine somatotrophin“. Veterinary Record 132, Nr. 21 (22.05.1993): 540. http://dx.doi.org/10.1136/vr.132.21.540-a.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
44

Salladay, S. A. „Should Christians Use Therapeutic Touch?“ Christian Bioethics 8, Nr. 1 (01.01.2002): 25–42. http://dx.doi.org/10.1076/chbi.8.1.25.8756.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
45

Little, John. „The therapeutic use of ‘no’“. Australasian Psychiatry 23, Nr. 2 (12.02.2015): 136–38. http://dx.doi.org/10.1177/1039856214568225.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
46

Cohen, Susan M., Mary Ellen Rousseau und Elizabeth H. Robinson. „Therapeutic Use of Selected Herbs“. Holistic Nursing Practice 14, Nr. 3 (April 2000): 59–68. http://dx.doi.org/10.1097/00004650-200004000-00010.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
47

Cazenave, S. O. S., C. L. Correa, E. C. Freitas und L. Matias. „Unsanctioned use of therapeutic drugs“. Toxicology Letters 95 (Juli 1998): 122. http://dx.doi.org/10.1016/s0378-4274(98)80483-9.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
48

Oliviero, A. „C35 Therapeutic use of TMS“. Clinical Neurophysiology 119 (Mai 2008): S70. http://dx.doi.org/10.1016/s1388-2457(08)60267-9.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
49

Anderegg-Wirth, Elisabeth. „Tranquilizers: Therapeutic use and pharmacology“. Pharmaceutica Acta Helvetiae 72, Nr. 2 (April 1997): 123. http://dx.doi.org/10.1016/s0031-6865(97)00009-5.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
50

Stiehm, E. Richard. „Appropriate therapeutic use of immunoglobulin“. Transfusion Medicine Reviews 10, Nr. 3 (Juli 1996): 203–21. http://dx.doi.org/10.1016/s0887-7963(96)80060-5.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
Wir bieten Rabatte auf alle Premium-Pläne für Autoren, deren Werke in thematische Literatursammlungen aufgenommen wurden. Kontaktieren Sie uns, um einen einzigartigen Promo-Code zu erhalten!

Zur Bibliographie